Correlation Between GSK Plc and Roche Holding

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GSK Plc and Roche Holding at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GSK Plc and Roche Holding into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GSK plc and Roche Holding AG, you can compare the effects of market volatilities on GSK Plc and Roche Holding and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GSK Plc with a short position of Roche Holding. Check out your portfolio center. Please also check ongoing floating volatility patterns of GSK Plc and Roche Holding.

Diversification Opportunities for GSK Plc and Roche Holding

0.47
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GSK and Roche is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding GSK plc and Roche Holding AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Roche Holding AG and GSK Plc is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GSK plc are associated (or correlated) with Roche Holding. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Roche Holding AG has no effect on the direction of GSK Plc i.e., GSK Plc and Roche Holding go up and down completely randomly.

Pair Corralation between GSK Plc and Roche Holding

Assuming the 90 days horizon GSK plc is expected to generate 0.83 times more return on investment than Roche Holding. However, GSK plc is 1.21 times less risky than Roche Holding. It trades about 0.01 of its potential returns per unit of risk. Roche Holding AG is currently generating about 0.0 per unit of risk. If you would invest  1,646  in GSK plc on September 16, 2024 and sell it today you would earn a total of  37.00  from holding GSK plc or generate 2.25% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy96.07%
ValuesDaily Returns

GSK plc  vs.  Roche Holding AG

 Performance 
       Timeline  
GSK plc 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GSK plc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.
Roche Holding AG 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roche Holding AG has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's fundamental drivers remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

GSK Plc and Roche Holding Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GSK Plc and Roche Holding

The main advantage of trading using opposite GSK Plc and Roche Holding positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GSK Plc position performs unexpectedly, Roche Holding can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Roche Holding will offset losses from the drop in Roche Holding's long position.
The idea behind GSK plc and Roche Holding AG pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Bonds Directory
Find actively traded corporate debentures issued by US companies
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios